Summary:
Florida Pulmonary Research Institute is conducting a research study comparing the Efficacy of Symbicort® pMDI and Formoterol Turbuhaler in Reducing Exacerbations in Patients with Chronic Obstructive Pulmonary Disease.
Qualified Participants Must:
• Be 40 years of age or older
•
Have a current diagnosis of COPD
•
Have a documented history of 1 or more moderate or severe COPD exacerbations within the last year
Qualified Participants May Receive:
Compensation for time and travel.